Literature DB >> 7852596

Serovars of Mycobacterium avium complex isolated from patients in Denmark.

D S Askgaard1, S B Giese, S Thybo, A Lerche, J Bennedsen.   

Abstract

Danish isolates of Mycobacterium avium complex were serotyped by the use of seroagglutination. The most prevalent serovars among patients with AIDS (n = 89) were 4 and 6, while among non-AIDS patients the most prevalent serovars were 1, 6, and 4, with no major differences between those in patients with pulmonary disease (n = 65) and those in patients with lymph node infection (n = 58). The results suggest a Scandinavian distribution of serovars with a predominance of serovar 6 and fail to demonstrate any selective protection against different serovars by Mycobacterium bovis BCG vaccination.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7852596      PMCID： PMC264184          DOI： 10.1128/jcm.32.11.2880-2882.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  The "atypical" mycobacteria: recognition and disease association.

Authors:  L G Wayne
Journal:  Crit Rev Microbiol       Date:  1985       Impact factor: 7.624

2.  Mycobacterium avium complex infection in patients with the acquired immunodeficiency syndrome. A clinicopathologic study.

Authors:  J M Wallace; J B Hannah
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

3.  Serovars of Mycobacterium avium complex isolated from patients in Sweden.

Authors:  S E Hoffner; G Källenius; B Petrini; P J Brennan; A Y Tsang
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Geographic distribution, frequency, and specimen source of Mycobacterium avium complex serotypes isolated from patients with acquired immunodeficiency syndrome.

Authors:  M A Yakrus; R C Good
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

5.  Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics.

Authors:  T E Kiehn; F F Edwards; P Brannon; A Y Tsang; M Maio; J W Gold; E Whimbey; B Wong; J K McClatchy; D Armstrong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome.

Authors:  C R Horsburgh; D L Cohn; R B Roberts; H Masur; R A Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 7.  Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects.

Authors:  G L Woods; J A Washington
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

Review 8.  Autopsy pathology in the acquired immune deficiency syndrome.

Authors:  C M Reichert; T J O'Leary; D L Levens; C R Simrell; A M Macher
Journal:  Am J Pathol       Date:  1983-09       Impact factor: 4.307

9.  Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome.

Authors:  A M Macher; J A Kovacs; V Gill; G D Roberts; J Ames; C H Park; S Straus; H C Lane; J E Parrillo; A S Fauci
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

10.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.

Authors:  C C Hawkins; J W Gold; E Whimbey; T E Kiehn; P Brannon; R Cammarata; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391
View more
  8 in total

1.  Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia.

Authors:  M Picardeau; A Varnerot; T Lecompte; F Brel; T May; V Vincent
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Clinical and prognostic importance of serotyping Mycobacterium avium-Mycobacterium intracellulare complex isolates in human immunodeficiency virus-negative patients.

Authors:  Ryoji Maekura; Yoshinari Okuda; Atsusi Hirotani; Seigo Kitada; Touru Hiraga; Kenji Yoshimura; Ikuya Yano; Kazuo Kobayashi; Masami Ito
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Prevalence of Mycobacterium avium in slaughter pigs in The Netherlands and comparison of IS1245 restriction fragment length polymorphism patterns of porcine and human isolates.

Authors:  R E Komijn; P E de Haas; M M Schneider; T Eger; J H Nieuwenhuijs; R J van den Hoek; D Bakker; F G van Zijd Erveld; D van Soolingen
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Novel rhamnosyltransferase involved in biosynthesis of serovar 4-specific glycopeptidolipid from Mycobacterium avium complex.

Authors:  Yuji Miyamoto; Tetsu Mukai; Takashi Naka; Nagatoshi Fujiwara; Yumi Maeda; Masanori Kai; Seiko Mizuno; Ikuya Yano; Masahiko Makino
Journal:  J Bacteriol       Date:  2010-09-03       Impact factor: 3.490

5.  Multi-centre evaluation of the speed-oligo Mycobacteria assay for differentiation of Mycobacterium spp. in clinical isolates.

Authors:  Sabine Hofmann-Thiel; Laziz Turaev; Tarig Alnour; Lore Drath; Maria Müllerova; Harald Hoffmann
Journal:  BMC Infect Dis       Date:  2011-12-19       Impact factor: 3.090

6.  IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization.

Authors:  D van Soolingen; J Bauer; V Ritacco; S C Leão; I Pavlik; V Vincent; N Rastogi; A Gori; T Bodmer; C Garzelli; M J Garcia
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245.

Authors:  J Bauer; A B Andersen; D Askgaard; S B Giese; B Larsen
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

8.  Two markers, IS901-IS902 and p40, identified by PCR and by using monoclonal antibodies in Mycobacterium avium strains.

Authors:  P Ahrens; S B Giese; J Klausen; N F Inglis
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.